Gas therapy strategies for depression and schizophrenia: A review

被引:1
|
作者
Tao, Xun [1 ]
Zhu, Xiaoxuan [1 ]
Liu, Yang [2 ]
Wang, Ling [3 ]
Wang, Dan [4 ]
Sun, Lin [2 ]
Li, Changjiang [2 ]
Lian, Bo [5 ]
Wang, Yingshuai [5 ]
Chen, Feng [6 ,7 ]
机构
[1] Weifang Med Univ, Sch Clin Med, Weifang, Peoples R China
[2] Weifang Med Univ, Sch Psychol, Weifang, Shandong, Peoples R China
[3] Weifang Med Univ, Clin Competency Training Ctr, Med Expt & Training Ctr, Weifang, Shandong, Peoples R China
[4] Weifang Med Univ, Sch Fdn Med, Dept Phys Educ, Weifang, Peoples R China
[5] Weifang Med Univ, Dept Biosci & Technol, Weifang, Shandong, Peoples R China
[6] Weifang Med Univ, Sch Pract Teaching Management Dept, Weifang, Shandong, Peoples R China
[7] Weifang Med Univ, Sch Pract Teaching Management Dept, 7166 Baotong West St, Weifang 261053, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
carbon monoxide; depression; hydrogen; hydrogen sulfide; nitric oxide; schizophrenia; NITRIC-OXIDE DONOR; RECOGNITION MEMORY DEFICITS; ANXIOLYTIC-LIKE BEHAVIOR; ELEVATED PLUS-MAZE; HYDROGEN-SULFIDE; SODIUM-NITROPRUSSIDE; OXIDATIVE STRESS; PARENTERAL NANOEMULSIONS; COGNITIVE IMPAIRMENT; ANTIDEPRESSANT-LIKE;
D O I
10.1097/MD.0000000000036156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Depression and schizophrenia are 2 serious mental disorders. Their effective treatment is an urgent medical and social problem at present. Drug treatment is the basic measure to improve mental disorders, especially serious mental disorders. However, the side effects of traditional antipsychotic drugs cannot be avoided. Surprisingly, in recent years, it has been found that nitric oxide (NO), carbon monoxide (CO), hydrogen sulfide (H2S) and hydrogen (H2) can regulate corresponding signal pathways to treat mental diseases in animal models. More importantly, as gas signal molecules, they will not bring toxicity and side effects after metabolism. Therefore, in this review, we analyzed the effects of gas on depression and schizophrenia through endogenous gas generation and external gas delivery strategies in some animal models. Endogenous gas generation strategy: summarized the therapeutic mechanism of gas signaling molecules on depression and schizophrenia, and listed the main ways to inhibit or stimulate gas generation. External gas delivery strategy: The common external stimuli-responsive gasotransmitter prodrugs and some study of these prodrugs in the treatment of depression and schizophrenia are summarized. We also analyzed the prospects of nano-gas carrier in the treatment of depression and schizophrenia. Through this review, we hope to provide guidance for treating depression and schizophrenia by regulating relevant gas signal pathways, and provide reference for developing safe and effective drugs for treating mental disorders by summarizing exogenous gas drugs.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] POSTPSYCHOTIC DEPRESSION IN SCHIZOPHRENIA
    CHINTALAPUDI, M
    KULHARA, P
    AVASTHI, A
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1993, 243 (02) : 103 - 108
  • [32] Structural network changes in patients with major depression and schizophrenia treated with electroconvulsive therapy
    Wolf, Robert Christian
    Nolte, Henrike Maria
    Hirjak, Dusan
    Hofer, Stefan
    Seidl, Ulrich
    Depping, Matte Sebastian
    Stieltjes, Bram
    Maier-Hein, Klaus
    Sambataro, Fabio
    Thomann, Philipp Arthur
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (09) : 1465 - 1474
  • [33] Bupropion for Depression in Schizophrenia
    Englisch, Susanne
    Inta, Dragos
    Esser, Andrea
    Zink, Mathias
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (05) : 257 - 259
  • [34] Management of depression in patients with schizophrenia spectrum disorders: a critical review of international guidelines
    Donde, C.
    Vignaud, P.
    Poulet, E.
    Brunelin, J.
    Haesebaert, F.
    ACTA PSYCHIATRICA SCANDINAVICA, 2018, 138 (04) : 289 - 299
  • [35] rTMS strategies for the study and treatment of schizophrenia: a review
    Stanford, Arielle D.
    Sharif, Zafar
    Corcoran, Cheryl
    Urban, Nina
    Malaspina, Dolores
    Lisanby, Sarah H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 (04) : 563 - 576
  • [36] Neuromodulation in response to electroconvulsive therapy in schizophrenia and major depression
    Thomann, Philipp Arthur
    Wolf, Robert Christian
    Nolte, Henrike Maria
    Hirjak, Dusan
    Hofer, Stefan
    Seidl, Ulrich
    Depping, Malte Sebastian
    Stieltjes, Bram
    Maier-Hein, Klaus
    Sambataro, Fabio
    Wuestenberg, Torsten
    BRAIN STIMULATION, 2017, 10 (03) : 637 - 644
  • [37] Cognitive impairment in schizophrenia and depression: A comparison of stability and course
    Neu, Peter
    Gooren, Tina
    Niebuhr, Ulrike
    Schlattmann, Peter
    APPLIED NEUROPSYCHOLOGY-ADULT, 2019, 26 (03) : 215 - 228
  • [38] THE OVERLAP OF COGNITIVE IMPAIRMENT IN DEPRESSION AND SCHIZOPHRENIA: A COMPARATIVE STUDY
    Sostaric, Mojca
    Zalar, Bojan
    PSYCHIATRIA DANUBINA, 2011, 23 (03) : 251 - 256
  • [39] Gas-Mediated Cancer Bioimaging and Therapy
    Chen, Lichan
    Zhou, Shu-Feng
    Su, Lichao
    Song, Jibin
    ACS NANO, 2019, 13 (10) : 10887 - 10917
  • [40] Mini-review: Brain energy metabolism and its role in animal models of depression, bipolar disorder, schizophrenia and autism
    Kolar, David
    Kleteckova, Lenka
    Brozka, Hana
    Vales, Karel
    NEUROSCIENCE LETTERS, 2021, 760